Entries by aaron

Bond policy issue raised at NHRC meeting, Is abolishing likely?

New Delhi: The issue of Bond policy was raised during the meeting held today by the National Human Rights Commission (NHRC). In the meeting, the National Medical Commission (NMC) officials including the Chairman Dr B Gangadhar and Secretary Dr B Srinivas were also present and the Commission expressed its plans regarding the bond policy in […]

GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine

New Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase III clinical trial of the antimicrobial drug Tafenoquine Tablets 50 mg /150 mg, used to prevent and to treat malaria. However, this approval is subject to the […]

USFDA issues EIR for Lupin Aurangabad facility

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Aurangabad manufacturing facility. The inspection was conducted from March 6 to March 15, 2024. Read also: Lupin gets one USFDA observation for Aurangabad facility The U.S. FDA […]

NEET 2024 Exam City Intimation slip released

New Delhi- The National Testing Agency (NTA) has finally made the National Eligibility cum Entrance Test (NEET-UG) 2024 exam city slip live on its official website. Also Read: NEET 2024 Exam City Slip, admit card to be released Soon Candidates can now download the exam city slip from the NTA website. Following are the steps to […]

Diabetes Increases Risk of Infection After Ankle Replacement Surgery, Study Finds

Patients with diabetes undergoing total ankle arthroplasty (TAA) face a significantly higher risk of postoperative infections compared to those without the condition, according to a new study. The study results were published in the journal Foot Ankle International.  The research, drawing on data from over 8,000 patients, highlights the increased challenges diabetic patients may encounter […]

SGLT2 Inhibitors vs. DPP4 Inhibitors: Study reveals new benefits of SGLT2i for prevention of hypertension

Japan: A recent study published in Hypertension Research using nationwide real-world data demonstrated the potential advantage of SGLT2 inhibitors over DPP4 inhibitors in reducing hypertension development in patients with diabetes. In the realm of hypertension management, the emergence of novel pharmacotherapies has sparked interest in their comparative effectiveness. Among these, sodium-glucose co-transporter 2 (SGLT2) inhibitors […]

Low Insulin Sensitivity Linked to Albuminuria Development in Diabetes Patients: Study

A recent study uncovered a significant link between reduced insulin sensitivity and the development of albuminuria, a key marker of kidney damage, in individuals with diabetes. This finding were published in the journal of Diabetes, Obesity and Metabolism. This study was conducted among Southwestern Indigenous American adults to investigate the association between insulin action and secretion […]